EICHORCondition: Influenza A · Sponsor: Janssen Research & Development, LLC
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to evaluate the clinical and virologic benefit of pimodivir in combination with Standard-of-Care (SOC) treatment compared to placebo in combination with SOC treatment.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Nea Baptist Clinic | Jonesboro, Arkansas, United States | — |
| UCSF Fresno | Fresno, California, United States | — |
| Miller Children's at Long Beach Medical Center | Long Beach, California, United States | — |
| Stanford University School of Medicine | Stanford, California, United States | — |
| Destin Pulmonary Critical Care, PLLS. | Santa Rosa Beach, Florida, United States | — |
| Northside Hospital | Atlanta, Georgia, United States | — |
| Augusta University | Augusta, Georgia, United States | — |
| Anne Arundel Medical Center | Annapolis, Maryland, United States | — |
| University Of Maryland Medical Center | Baltimore, Maryland, United States | — |
| Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| Wayne State Univ School of Medicine | Detroit, Michigan, United States | — |
+ 257 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03376321